Monitoring the sensitivity of influenza viruses to oseltamivir, in Romania, from 2016 to 2023
Introduction: influenza is an acute viral disease caused by infection of the upper respiratory tract - difficult to control, which affects a large part of the population. Neuraminidase inhibitors (NAIs), such as oseltamivir and zanamivir, are the antiviral drugs utilized in Romania for the treatment...
Κύριοι συγγραφείς: | Mihai Maria Elena, Ivanciuc Alina Elena, Cherciu Carmen Maria, Mihăescu Grigore, Lazăr Mihaela |
---|---|
Μορφή: | Άρθρο |
Γλώσσα: | English |
Έκδοση: |
Sciendo
2024-04-01
|
Σειρά: | Romanian Journal of Laboratory Medicine |
Θέματα: | |
Διαθέσιμο Online: | https://doi.org/10.2478/rrlm-2024-0010 |
Παρόμοια τεκμήρια
-
Interferon Lambda Delays the Emergence of Influenza Virus Resistance to Oseltamivir
ανά: Chiara Medaglia, κ.ά.
Έκδοση: (2021-06-01) -
Discovery of oseltamivir-based novel PROTACs as degraders targeting neuraminidase to combat H1N1 influenza virus
ανά: Zhichao Xu, κ.ά.
Έκδοση: (2022-06-01) -
Multicountry Spread of Influenza A(H1N1)pdm09 Viruses with Reduced Oseltamivir Inhibition, May 2023–February 2024
ανά: Mira C. Patel, κ.ά.
Έκδοση: (2024-07-01) -
Oseltamivir-Resistant Pandemic (H1N1) 2009 Virus, South Korea
ανά: Hwajung Yi, κ.ά.
Έκδοση: (2010-12-01) -
Assessment of influenza A (H1N1, H3N2) oseltamivir resistance during 2017-2019 in Iran
ανά: Amytis Gholami, κ.ά.
Έκδοση: (2022-08-01)